BBHVanEck Vectors Biotech ETF
Fund Description
VanEck Vectors® Biotech ETF (BBH) seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the MVIS® US Listed Biotech 25 Index (MVBBHTR), which is intended to track the overall performance of companies involved in the development and production, marketing and sales of drugs based on genetic analysis and diagnostic equipment.
-
Fund Ticker
BBH -
Exchange
NASDAQ -
ETF Structure
Physical -
Administrator
Van Eck Associates -
Custodian
State Street Bank and Trust Company -
Index Ticker
MVBBHTR -
Index Rebalancing
Quarterly
as of 03/08/21
-
30-Day SEC Yield1
0.27% -
Total Net Assets
$463.7M -
Number of Holdings
24 -
Options
Available -
Gross Expense Ratio2
0.39% -
Net Expense Ratio/TER2
0.35% -
Distribution Frequency
Annual
Portfolio Composition (%)
as of 03/05/21
- % of Net Assets
-
Stocks
99.81 -
Bonds
0.00 -
Other
0.00 -
Cash
0.19
Daily Holdings (%) as of 03/05/21 Daily Holdings
Total Holdings: 24
|
Ticker
|
Holding Name |
Identifier (FIGI)
|
Shares | Asset Class |
Market Value (US$) |
% of Net Assets |
|---|---|---|---|---|---|---|
|
AMGN US
|
Amgen Inc |
BBG000BBS2Y0
|
263,654
|
Stock | 60,041,925 | 12.68 |
|
GILD US
|
Gilead Sciences Inc |
BBG000CKGBP2
|
486,603
|
Stock | 31,444,286 | 6.64 |
|
ILMN US
|
Illumina Inc |
BBG000DSMS70
|
68,946
|
Stock | 27,499,112 | 5.81 |
|
ALXN US
|
Alexion Pharmaceuticals Inc |
BBG000G30YX4
|
178,007
|
Stock | 26,718,851 | 5.64 |
|
IQV US
|
Iqvia Holdings Inc |
BBG00333FYS2
|
138,204
|
Stock | 26,090,151 | 5.51 |
|
BIIB US
|
Biogen Inc |
BBG000C17X76
|
95,149
|
Stock | 25,757,786 | 5.44 |
|
MRNA US
|
Moderna Inc |
BBG003PHHZT1
|
167,574
|
Stock | 22,151,607 | 4.68 |
|
VRTX US
|
Vertex Pharmaceuticals Inc |
BBG000C1S2X2
|
103,785
|
Stock | 22,000,344 | 4.65 |
|
REGN US
|
Regeneron Pharmaceuticals Inc |
BBG000C734W3
|
47,657
|
Stock | 21,997,041 | 4.65 |
|
EXAS US
|
Exact Sciences Corp |
BBG000CWL0F5
|
160,812
|
Stock | 19,561,172 | 4.13 |
|
GH US
|
Guardant Health Inc |
BBG006D97VY9
|
143,081
|
Stock | 19,354,567 | 4.09 |
|
CRL US
|
Charles River Laboratories Internationa |
BBG000BG5BL8
|
70,231
|
Stock | 19,230,652 | 4.06 |
|
NVAX US
|
Novavax Inc |
BBG000NVSBL7
|
108,347
|
Stock | 18,943,389 | 4.00 |
|
SGEN US
|
Seagen Inc |
BBG000BH0FR6
|
115,563
|
Stock | 17,259,334 | 3.65 |
|
INCY US
|
Incyte Corp |
BBG000BNPSQ9
|
203,303
|
Stock | 16,317,099 | 3.45 |
|
QGEN US
|
Qiagen Nv |
BBG000GTYWL7
|
314,114
|
Stock | 14,926,697 | 3.15 |
|
ALNY US
|
Alnylam Pharmaceuticals Inc |
BBG000BFGNJ5
|
103,362
|
Stock | 14,821,077 | 3.13 |
|
BNTX US
|
Biontech Se |
BBG00Q70B3V1
|
153,678
|
Stock | 14,783,824 | 3.12 |
|
BMRN US
|
Biomarin Pharmaceutical Inc |
BBG000CZWZ05
|
189,588
|
Stock | 14,736,675 | 3.11 |
|
NBIX US
|
Neurocrine Biosciences Inc |
BBG000GJS7C1
|
97,577
|
Stock | 9,097,104 | 1.92 |
|
BGNE US
|
Beigene Ltd |
BBG00B6WF7T5
|
29,897
|
Stock | 9,007,368 | 1.90 |
|
SRPT US
|
Sarepta Therapeutics Inc |
BBG000BCJ161
|
94,625
|
Stock | 8,023,254 | 1.69 |
|
IONS US
|
Ionis Pharmaceuticals Inc |
BBG000JH6683
|
124,396
|
Stock | 6,565,621 | 1.39 |
|
QDEL US
|
Quidel Corp |
BBG000C6GN04
|
41,494
|
Stock | 6,278,042 | 1.33 |
|
--
|
Other/Cash |
--
|
--
|
Cash | 876,344 | 0.19 |
← Scroll for more information →
These are not recommendations to buy or to sell any security. Securities and holdings may vary.